Induction_NN
of_IN
endothelial_JJ
cell_NN
surface_NN
adhesion_NN
molecules_NNS
by_IN
tumor_NN
necrosis_NN
factor_NN
is_VBZ
blocked_VBN
by_IN
protein_NN
tyrosine_NN
phosphatase_NN
inhibitors_NNS
:_:
role_NN
of_IN
the_DT
nuclear_JJ
transcription_NN
factor_NN
NF-kappa_NN
B_NN
._.

Recent_JJ
studies_NNS
from_IN
our_PRP$
laboratory_NN
have_VBP
indicated_VBN
that_IN
protein_NN
tyrosine_NN
phosphatase_NN
-LRB-_-LRB-
PTPase_NN
-RRB-_-RRB-
inhibitors_NNS
can_MD
down-modulate_VB
the_DT
tumor_NN
necrosis_NN
factor_NN
-LRB-_-LRB-
TNF_NN
-RRB-_-RRB-
-_:
mediated_JJ
activation_NN
of_IN
the_DT
nuclear_JJ
transcription_NN
factor_NN
NF-kappa_NN
B_NN
in_IN
ML-1a_NN
,_,
a_DT
monocytic_JJ
cell_NN
line_NN
-LRB-_-LRB-
Singh_NNP
and_CC
Aggarwal_NNP
,_,
J._NNP
Biol_NNP
._.
Chem_NNP
._.
1995_CD
:_:
270_CD
:_:
10631_CD
-RRB-_-RRB-
._.

Since_IN
TNF_NN
is_VBZ
one_CD
of_IN
the_DT
major_JJ
inducers_NNS
of_IN
various_JJ
adhesion_NN
molecules_NNS
in_IN
human_JJ
endothelial_JJ
cells_NNS
and_CC
their_PRP$
expression_NN
is_VBZ
known_VBN
to_TO
require_VB
the_DT
activation_NN
of_IN
NF-kappa_NN
B_NN
,_,
we_PRP
examined_VBD
the_DT
effect_NN
of_IN
PTPase_NN
inhibitors_NNS
on_IN
the_DT
TNF-mediated_JJ
induction_NN
of_IN
intracellular_JJ
adhesion_NN
molecule_NN
-LRB-_-LRB-
ICAM_NN
-RRB-_-RRB-
-1_CD
,_,
vascular_JJ
cell_NN
adhesion_NN
molecule_NN
-LRB-_-LRB-
VCAM_NN
-RRB-_-RRB-
-1_CD
and_CC
endothelial_JJ
leukocyte_NN
adhesion_NN
molecule_NN
-LRB-_-LRB-
ELAM_NN
-RRB-_-RRB-
-1_CD
._.

Like_IN
ML-1a_NN
,_,
human_JJ
dermal_JJ
microvessel_NN
endothelial_JJ
cells_NNS
-LRB-_-LRB-
MVEC_NNS
-RRB-_-RRB-
treated_VBN
with_IN
TNF_NN
rapidly_RB
activated_VBD
-LRB-_-LRB-
within_IN
30_CD
min_NN
-RRB-_-RRB-
NF-kappa_NN
B_NN
;_:
this_DT
effect_NN
was_VBD
completely_RB
abolished_VBN
by_IN
co-treatment_NN
with_IN
phenylarsine_NN
oxide_NN
-LRB-_-LRB-
PAO_NN
-RRB-_-RRB-
,_,
a_DT
specific_JJ
inhibitor_NN
of_IN
PTPase_NN
._.

The_DT
induction_NN
of_IN
ICAM-1_NN
,_,
VCAM-1_NN
,_,
and_CC
ELAM-1_NN
by_IN
TNF_NN
in_IN
MVEC_NNS
occurred_VBD
within_IN
6_CD
h_NN
and_CC
was_VBD
also_RB
completely_RB
down-regulated_VBN
by_IN
PAO_NN
in_IN
a_DT
dose-dependent_JJ
manner_NN
._.

PAO_NN
was_VBD
found_VBN
to_TO
be_VB
effective_JJ
even_RB
when_WRB
added_VBN
3_CD
h_NN
after_IN
TNF_NN
,_,
suggesting_VBG
a_DT
rapid_JJ
mode_NN
of_IN
action_NN
of_IN
this_DT
inhibitor_NN
._.

Besides_IN
PAO_NN
,_,
other_JJ
inhibitors_NNS
of_IN
PTPase_NN
,_,
including_VBG
pervanadate_NN
and_CC
diamide_NN
,_,
also_RB
blocked_VBD
TNF-dependent_JJ
NF-kappa_NN
B_NN
activation_NN
and_CC
induction_NN
of_IN
all_PDT
the_DT
three_CD
adhesion_NN
proteins_NNS
._.

Consistent_JJ
with_IN
these_DT
results_NNS
,_,
the_DT
attachment_NN
of_IN
monocytes_NNS
to_TO
MVEC_NNS
was_VBD
also_RB
blocked_VBN
by_IN
the_DT
PTPase_NN
inhibitors_NNS
._.

Thus_RB
,_,
overall_RB
,_,
our_PRP$
results_NNS
demonstrate_VBP
that_IN
a_DT
PTPase_NN
is_VBZ
involved_VBN
either_CC
directly_RB
or_CC
indirectly_RB
in_IN
the_DT
pathway_NN
leading_VBG
to_TO
the_DT
induction_NN
of_IN
endothelial_JJ
cell_NN
adhesion_NN
molecules_NNS
by_IN
TNF_NN
._.

Because_IN
of_IN
their_PRP$
role_NN
in_IN
cell_NN
adhesion_NN
,_,
PTPase_NN
may_MD
provide_VB
a_DT
novel_JJ
target_NN
of_IN
drug_NN
development_NN
for_IN
treatment_NN
of_IN
inflammation_NN
,_,
atherogenesis_NN
,_,
and_CC
tumor_NN
metastasis_NN
._.

